chlormerodrin Report issue

Small molecule Experimental
ChEMBL DrugBank Drug Central MeSH PubChem

Active Ingredient History

Chlormerodrin is a mercurial diuretic commercially traded from 1952 until 1974 that was once used to treat patients with heart failure, but is no longer in widespread use. The radiolabelled form had also been used for medical imaging of the kidney and brain and the 197Hg form was even considered a contender for 99mTc by some physicians, but was ultimately discontinued by the FDA in 1989.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

1-[3-(chloromercuri)-2-methoxypropyl]urea | 197hg | {3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury | chlormerodrin | chlormerodrin (197hg) | chlormerodrina | chlormerodrine | chlormerodrin hg 197 | chlormerodrinum | chlormeroprin | mercloran | neohydrin | neohydrin-197 | promeran | promeranum

Indications (2)

Approved Indications (2)


 

Heart Failure (approved 1952)

Neoplasms

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue